Showing results (111-120 of 137) with videos related to
Sort By:
Pageof 14
Nature Genetics|October 2, 2002
Chromosomal instability in ulcerative colitis is related to telomere shorteningJacintha N O'Sullivan, Mary P Bronner, Teresa A Brentnall, et al.Cancer Letters|December 30, 2008
Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosisAlan Coss, Miriam Tosetto, Edward J Fox, et al.Molecular Cancer Therapeutics|June 8, 2012
Inhibition of dendritic cell maturation by the tumor microenvironment correlates with the survival of colorectal cancer patients following bevacizumab treatmentAdriana J Michielsen, Sinead Noonan, Petra Martin, et al.Trials|June 15, 2019
CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trialRavindra Dotel, Steven Y C Tong, Asha Bowen, et al.Viruses|September 27, 2025
Genomic Evolution of SARS-CoV-2 Variants of Concern Under In Vitro Neutralising Selection Pressure Following Two Doses of the Pfizer-BioNTech BNT162b2 COVID-19 VaccineKerri Basile, Jessica E Agius, Winkie Fong, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 26, 2021
An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian populationMichael C Wehrhahn, Suzanne J Brown, James P Newcombe, et al.Antimicrobial Agents and Chemotherapy|January 22, 2013
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremiaNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2013
Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemiaN E Holmes, J D Turnidge, W J Munckhof, et al.The Journal of Infectious Diseases|July 12, 2011
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrationsNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.Journal of Clinical Microbiology|July 18, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolatesNatasha E Holmes, John D Turnidge, Wendy J Munckhof, et al.Pageof 14